Live from the NIH registry
Studies recruiting near Lancaster right now
Top 25 of 102 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 2
Interventional 224 participants sought
Gastro Care Institute — Lancaster, California (2.2 mi)
· Sponsor: Genentech, Inc.
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Diabetes Mellitus, Type 2
Phase 2
Interventional 270 participants sought
First Valley Medical Group — Lancaster, California (2.2 mi)
· Sponsor: Novo Nordisk A/S
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
Urinary Tract Infections
Phase 2
Interventional 318 participants sought
Research Site 131 — Lancaster, California (2.2 mi)
· Sponsor: Locus Biosciences
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Lancaster, California (2.2 mi)
· Sponsor: Hoffmann-La Roche
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Crohn's Disease
Phase 3
Interventional 1,200 participants sought
Om Research LLC ( Site 5038) — Lancaster, California (2.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 19 — Palmdale, California (8.6 mi)
· Sponsor: BioStem Technologies
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: SWOG Cancer Research Network
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 2
Interventional 82 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: City of Hope Medical Center
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: Canadian Cancer Trials Group
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small-Cell Lung
Phase 2
Interventional 480 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Om Research, LLC 1 — Lancaster, California (2.2 mi)
· Sponsor: Janssen Research & Development, LLC
Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference
Colonic Polyps
N/A
Interventional 330 participants sought
Gastro Care Institute — Lancaster, California (2.2 mi)
· Sponsor: Capso Vision, Inc.
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus, T2DM
Phase 2
Interventional 180 participants sought
Care Access Research - Santa Clarita — Santa Clarita, California (29.5 mi)
· Sponsor: Hanmi Pharmaceutical Company Limited
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
Ulcerative Colitis
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400006 — Lancaster, California (2.2 mi)
· Sponsor: Sanofi
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Om Research LLC — Lancaster, California (2.2 mi)
· Sponsor: Ardelyx
A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
Severe Asthma
Phase 2
Interventional 512 participants sought
Research site — Lancaster, California (2.2 mi)
· Sponsor: Kinaset Therapeutics Inc
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 3
Interventional 269 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: NRG Oncology
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Om Research LLC — Lancaster, California (2.2 mi)
· Sponsor: Eli Lilly and Company
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Diabetic Kidney Disease (DKD)
Phase 2
Interventional 195 participants sought
Amicis Research Center — Santa Clarita, California (29.5 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Vitiligo, Non-Segmental Vitiligo (NSV)
Phase 2
Interventional 66 participants sought
Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway — Santa Clarita, California (29.5 mi)
· Sponsor: Eli Lilly and Company
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Lancaster, California (2.2 mi)
· Sponsor: Akero Therapeutics, Inc
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma
Phase 2
Interventional 227 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: SWOG Cancer Research Network
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
USC Norris Santa Clarita Oncology — Santa Clarita, California (29.5 mi)
· Sponsor: NRG Oncology